Skip to main content
Equibles

STATE STREET CORP

Position in ACHV — Achieve Life Sciences, Inc.

CIK 93751 BOSTON, MA
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$19,234,284
+$18,486,181 QoQ
Shares Held
2,945,526
+1057.6% QoQ
Ownership
2.86%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 111 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. ACHV ranks #165 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in ACHV

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,234,284 2,945,526
2026-03-31 $748,103 254,457
2025-12-31 $1,164,257 234,257
2025-09-30 $694,209 220,384
2025-06-30 $356,817 157,884
2025-03-31 $1,210,631 453,420
2024-12-31 $1,536,374 436,470
2024-09-30 $2,045,404 431,520
2024-06-30 $1,899,274 404,101
2024-03-31 $251,232 55,216
2023-12-31 $260,861 63,316
2023-09-30 $272,258 63,316
2023-06-30 $328,610 63,316
2023-03-31 $186,428 27,416
2022-12-31 $55,654 22,716
2022-09-30 $74,962 22,716
2022-06-30 $110,854 22,716
2022-03-31 $141,793 18,731
2021-12-31 $114,840 14,761
2021-09-30 $125,468 14,761
2021-06-30 $132,553 14,761